Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections.
about
Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseasesEffect of chicken egg yolk antibodies (IgY) against diarrhea in domesticated animals: a systematic review and meta-analysis.Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases--A review.Efficient and Durable Vaccine against Intimin β of Diarrheagenic E. Coli Induced by Clay Nanoparticles.Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H-.Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models.The development of IgY(DeltaFc) antibody based neuro toxin antivenoms and the study on their neutralization efficacies.
P2860
Q28743696-EF761A8E-96AB-4514-B9D7-6CB8DB233CC6Q33638281-AA09E956-CCAE-4FF2-9D79-7AB15401E3C6Q38633565-3FECB804-DB86-48A6-97EB-1B53D5103249Q39900815-650BA3AF-B847-4692-B1EE-BDA1B8F3C9ECQ42084913-A5E8D6BB-A7C5-477F-8235-DA700AEDF07EQ43518801-BE12B012-B8B4-4A39-BD6C-2B20792D9807Q51696604-9D65436E-4C10-48E4-BE73-DD77C70D8FC7
P2860
Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Use of virulence factor-specif ...... g Escherichia coli infections.
@en
Use of virulence factor-specif ...... g Escherichia coli infections.
@nl
type
label
Use of virulence factor-specif ...... g Escherichia coli infections.
@en
Use of virulence factor-specif ...... g Escherichia coli infections.
@nl
prefLabel
Use of virulence factor-specif ...... g Escherichia coli infections.
@en
Use of virulence factor-specif ...... g Escherichia coli infections.
@nl
P2093
P1476
Use of virulence factor-specif ...... g Escherichia coli infections.
@en
P2093
Cynthia Breton
Francis Girard
Gabriela Martinez
Isabelle Batisson
John M Fairbrother
Josée Harel
P304
P356
10.1111/J.1574-695X.2005.00030.X
P577
2006-04-01T00:00:00Z